Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly Allott

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
The Australian and New Zealand Journal of Psychiatry|April 18, 2019
Harmonised collection of data in youth mental health: Towards large datasetsSuzie Lavoie, Kelly Allott, Paul Amminger, et al.
Biological Psychiatry|February 18, 2019
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B<sub>12</sub>, B<sub>6</sub>, and Folic Acid on Symptoms and Neurocognition in First-Episode PsychosisKelly Allott, Patrick D McGorry, Hok Pan Yuen, et al.
Psychiatric Rehabilitation Journal|July 25, 2024
An ethics analysis of antipsychotic dose reduction and discontinuation: Principles for supporting recovery from psychosisKelly Allott, Allie Pert, Audrey Rattray, et al.
Child and Adolescent Mental Health|April 29, 2021
The Neuropsychological Symptoms Self-Report: psychometric properties in an adolescent and young adult mental health cohortKelly Allott, Caroline X Gao, Caroline Fisher, et al.
Schizophrenia Research|July 29, 2014
Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosisSung-Wan Kim, Miriam R Schäfer, Claudia M Klier, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 3, 2019
Testing a neurophenomenological model of basic self disturbance in early psychosisBarnaby Nelson, Suzie Lavoie, Lukasz Gaweda, et al.
Psychiatric Rehabilitation Journal|July 18, 2024
The liminal space of first-episode psychosis and its treatment: A qualitative study exploring the experience of young people participating in an antipsychotic dose reduction randomized controlled trialJesse Gates, Carli Ellinghaus, Lee Valentine, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 10, 2019
The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trialsJoseph Firth, Scott B Teasdale, Kelly Allott, et al.
Schizophrenia Research|January 12, 2021
Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognitionJessica Spark, Łukasz Gawęda, Kelly Allott, et al.
Schizophrenia Bulletin|October 16, 2018
Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-upKelly Allott, Stephen J Wood, Hok Pan Yuen, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
The Australian and New Zealand Journal of Psychiatry|April 18, 2019
Harmonised collection of data in youth mental health: Towards large datasetsSuzie Lavoie, Kelly Allott, Paul Amminger, et al.
Biological Psychiatry|February 18, 2019
The Vitamins in Psychosis Study: A Randomized, Double-Blind, Placebo-Controlled Trial of the Effects of Vitamins B<sub>12</sub>, B<sub>6</sub>, and Folic Acid on Symptoms and Neurocognition in First-Episode PsychosisKelly Allott, Patrick D McGorry, Hok Pan Yuen, et al.
Psychiatric Rehabilitation Journal|July 25, 2024
An ethics analysis of antipsychotic dose reduction and discontinuation: Principles for supporting recovery from psychosisKelly Allott, Allie Pert, Audrey Rattray, et al.
Child and Adolescent Mental Health|April 29, 2021
The Neuropsychological Symptoms Self-Report: psychometric properties in an adolescent and young adult mental health cohortKelly Allott, Caroline X Gao, Caroline Fisher, et al.
Schizophrenia Research|July 29, 2014
Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosisSung-Wan Kim, Miriam R Schäfer, Claudia M Klier, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|January 3, 2019
Testing a neurophenomenological model of basic self disturbance in early psychosisBarnaby Nelson, Suzie Lavoie, Lukasz Gaweda, et al.
Psychiatric Rehabilitation Journal|July 18, 2024
The liminal space of first-episode psychosis and its treatment: A qualitative study exploring the experience of young people participating in an antipsychotic dose reduction randomized controlled trialJesse Gates, Carli Ellinghaus, Lee Valentine, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 10, 2019
The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trialsJoseph Firth, Scott B Teasdale, Kelly Allott, et al.
Schizophrenia Research|January 12, 2021
Distinguishing schizophrenia spectrum from non-spectrum disorders among young patients with first episode psychosis and at high clinical risk: The role of basic self-disturbance and neurocognitionJessica Spark, Łukasz Gawęda, Kelly Allott, et al.
Schizophrenia Bulletin|October 16, 2018
Longitudinal Cognitive Performance in Individuals at Ultrahigh Risk for Psychosis: A 10-year Follow-upKelly Allott, Stephen J Wood, Hok Pan Yuen, et al.
Pageof 14